期刊
CURRENT OPINION IN VIROLOGY
卷 20, 期 -, 页码 64-70出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.coviro.2016.09.005
关键词
-
类别
资金
- European Commission [H2020-MSCA-IF-2015-705518]
- NIH [PO1 AI070167]
- ANR [ANR-13-BSV3-009]
- Infect-ERA [ANR-14-IFEC-0005]
- Investissements d'Avenir Programs [ANR-10-LABX-36, ANR-11-EQPX-0022]
- Fondation ARC
Developing antiviral drugs is challenging due to the small number of targets in viruses, and the rapid evolution of viral genes. Animals have evolved a number of efficient antiviral defence mechanisms, which can serve as a source of inspiration for novel therapies. The genetically tractable insect Drosophila belongs to the most diverse group of animals. Genetic and transcriptomic analyses have recently identified Drosophila genes encoding viral restriction factors. Some of them represent evolutionary novelties and their characterization may provide hints for the design of directly acting antivirals. In addition, functional screens revealed conserved host factors required for efficient viral translation, such as the ribosomal protein RACK1 and the release factor Pelo. These proteins are promising candidates for host targeted antivirals.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据